The Claim
In hypercholesterolemic adults receiving statin therapy, subcutaneous administration of AMG 145 at doses up to 420 mg every 4 weeks results in sustained low-density lipoprotein cholesterol (LDL-C) reductions exceeding 60% throughout the entire dosing interval, supporting the feasibility of monthly dosing regimens.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
A shot called AMG 145, given once a month, can cut bad cholesterol by more than 60% in people already on cholesterol meds — and it stays effective the whole month.
See the scientific wording
AMG 145 administered subcutaneously at doses up to 420 mg every 4 weeks causes sustained LDL-C reductions greater than 60% over the entire dosing interval, supporting the feasibility of monthly dosing regimens in hypercholesterolemic adults on statin therapy.
What the research says
1 studyThe study tested the same drug and dose described in the claim and found it lowered bad cholesterol by more than 60%, just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.